Skip to main content
    S

    Sensus Healthcare Inc (SRTS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.34
    +0.02 (+0.65%)

    Market Cap: $38.27M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sensus Healthcare Inc (SRTS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Sensus Healthcare reported revenue of $27.48M for the fiscal year ended Dec 31, 2025, down 34.3% from the year before. That year, net income was -$7.72M with a net margin of -28.1%, operating cash flow was $528.00K and free cash flow was $332.00K. The quarter ended Sep 30, 2026 had revenue of $6.00M and net income of -$1.49M.

    Revenue and Margins

    The operating margin was -37.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $14.81M, a compound annual rate of 7.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$27.48M-34.3%43.2%-37.5%-28.1%
    Dec 2024$41.81M+71.3%58.4%19.4%15.9%
    Dec 2023$24.41M-45.2%57.6%-1.6%2.0%
    Dec 2022$44.53M+64.7%66.5%33.3%54.4%
    Dec 2021$27.04M+182.4%62.8%15.2%15.2%
    Dec 2020$9.58M-64.9%54.8%-86.0%-71.4%
    Dec 2019$27.26M+3.2%64.4%-7.2%-6.2%
    Dec 2018$26.43M+28.4%64.0%-7.6%-7.7%
    Dec 2017$20.59M+39.0%67.0%-18.1%-18.0%
    Dec 2016$14.81MN/A66.5%-2.5%-2.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$27.48M$41.81M$24.41M$44.53M$27.04M$9.58M$27.26M$26.43M$20.59M$14.81M
    Cost of revenue$15.62M$17.38M$10.35M$14.90M$10.05M$4.33M$9.71M$9.52M$6.79M$4.97M
    Gross profit$11.87M$24.43M$14.06M$29.63M$16.99M$5.25M$17.56M$16.91M$13.80M$9.85M
    Research and development$7.78M$4.22M$3.68M$3.46M$3.44M$4.16M$6.42M$6.26M$5.49M$1.82M
    Operating income-$10.31M$8.09M-$382.00K$14.83M$4.12M-$8.23M-$1.97M-$2.01M-$3.72M-$363.12K
    Net income-$7.72M$6.65M$485.00K$24.24M$4.12M-$6.84M-$1.70M-$2.02M-$3.71M-$346.45K
    EBITDA-$9.68M$8.52M$121.00K$28.50M$4.73M-$6.92M-$1.42M-$1.35M-$3.33M-$25.54K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$6.00M$2.29M$3.39M$4.94M$6.88M$7.32M$8.34M$13.07M$8.84M$9.24M$10.66M$12.57M
    Gross profit$3.29M$769.00K$991.00K$1.90M$2.71M$2.90M$4.35M$7.11M$5.24M$5.42M$6.66M$7.83M
    Operating income-$1.62M-$3.18M-$4.36M-$3.15M-$2.57M-$1.94M-$2.65M$1.73M$1.50M$1.98M$2.89M$5.58M
    Net income-$1.49M-$8.75M-$2.63M-$3.17M-$943.00K-$1.04M-$2.57M$1.55M$1.22M$1.61M$2.27M$4.21M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $262.00K by $21.82M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$53.04M$62.16M$53.71M$56.73M$32.24M$28.01M$36.92M$33.25M$18.84M$18.95M
    Current assets$45.89M$56.74M$49.53M$53.24M$31.25M$25.17M$34.00M$31.90M$17.89M$16.76M
    Cash and equivalents$22.08M$22.06M$23.15M$25.52M$14.52M$14.91M$8.10M$12.48M$10.09M$5.04M
    Total liabilities$4.94M$6.34M$4.87M$8.67M$6.22M$6.51M$8.92M$6.79M$7.15M$3.67M
    Short-term debt$262.00K$204.00K$187.00K$190.00K$51.00K$0$309.52K-$5.17M$2.21M-$2.76M
    Long-term debtN/AN/AN/AN/AN/A$267.00K$0N/A$2.21M$0
    Shareholder equity$48.10M$55.83M$48.84M$48.07M$26.02M$21.50M$28.00M$26.46M$11.68M$15.27M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$40.55M$41.26M$51.55M$53.04M$58.30M$58.85M$60.21M$62.16M$59.86M$58.16M$57.27M$53.71M
    Total liabilities$5.11M$4.40M$6.00M$4.94M$7.10M$6.79M$7.18M$6.34M$5.73M$5.26M$6.07M$4.87M
    Cash and equivalents$12.92M$15.19M$18.33M$22.08M$24.45M$22.16M$19.07M$22.06M$22.56M$18.97M$14.73M$23.15M
    Shareholder equity$35.44M$36.86M$45.54M$48.10M$51.19M$52.06M$53.03M$55.83M$54.13M$52.90M$51.21M$48.84M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 62.9% of operating cash flow. Share repurchases came to 90.4% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$528.00K-$831.00K-$2.15M-$1.41M-$286.00K-$434.00K-$2.11M-$8.56M-$3.06M-$3.85M
    Capital expenditures$196.00K$276.00K$229.00K$159.00K$128.00K$359.00K$400.59K$854.83K$287.59K$286.00K
    Free cash flow$332.00K-$1.11M-$2.37M-$1.57M-$414.00K-$793.00K-$2.51M-$9.42M-$3.34M-$4.14M
    Dividends paidN/AN/AN/A$731.00KN/A$210.34KN/AN/A$0$2.55M
    Share repurchases$300.00K$0$27.00K$3.00M$0N/AN/A$1.40M$0$2.13M
    Investing cash flow-$196.00K-$276.00K-$187.00K$14.84M$129.00K$7.03M-$4.90M-$2.64M$6.17M-$7.85M
    Financing cash flow-$305.00K$15.00K-$40.00K-$2.43M-$231.00K$211.00K$2.62M$13.60M$1.93M$8.68M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$2.26M-$3.13M-$3.75M-$2.21M$2.29M$3.12M-$2.68M-$827.00K$3.95M$4.23M-$8.19M$2.67M
    Capital expenditures$5.00K$8.00K$3.00K$158.00K$4.00K$27.00K$7.00K$297.00K$337.00K$3.00K$233.00K$229.00K
    Free cash flow-$2.27M-$3.14M-$3.76M-$2.37M$2.29M$3.09M-$2.68M-$1.12M$3.62M$4.23M-$8.42M$2.44M
    Last 12 quarters

    Frequently Asked Questions About SRTS

    What is Sensus Healthcare's annual revenue?

    Sensus Healthcare reported revenue of $27.48M for the fiscal year ended Dec 31, 2025.

    How fast is Sensus Healthcare's revenue growing?

    Revenue was down 34.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -14.9%.

    Is Sensus Healthcare profitable?

    No. Sensus Healthcare reported net income of -$7.72M for the fiscal year ended Dec 31, 2025, with a net margin of -28.1%.

    How much free cash flow does SRTS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $528.00K minus capital expenditures of $196.00K produced free cash flow of $332.00K.

    How much debt does Sensus Healthcare have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $262.00K and cash and equivalents of $22.08M.